Endocrine Today

09/30/2026

📢 Petrelintide was associated with weight loss of approximately 10% at 28 and 42 weeks in patients with obesity but not diabetes, with an adverse event profile similar to placebo.

Petrelintide, a novel amylin analog, was associated with up to 10% weight loss with a comparable adverse events profile to placebo at 28 and 42 weeks, according to results of the ZUPREME 1 phase 2 trial. For the trial, presented at the European Association for the Study of Diabetes annual meeting an...

09/30/2026

❓ Three topics clinicians should ask perimenopausal women about during clinic visits to assess menopausal symptoms include

📌 sleep disruptions
📌 mood changes
📌 brain fog

Many healthcare professionals do not attribute symptoms such as fatigue, mood changes or sleep disruptions to menopause, leading to a missed opportunity for proper treatment in midlife women, according to a speaker. Jila Senemar, MD, FACOG, founder and chief medical officer of JilaMD, said healthcar...

09/30/2026

💉 Retatrutide was linked to significant weight loss compared with placebo among adults with type 2 diabetes and overweight or obesity, according to data from the TRIUMPH-2 trial presented at EASD 2026.

Read more about the study 👇

Once-weekly retatrutide induced weight loss of up to 18.8% at 80 weeks for adults with type 2 diabetes plus overweight or obesity, according to findings from the phase 3 TRIUMPH-2 trial. As Healio previously reported, adults with overweight or obesity without diabetes receiving once-weekly subcutane...

09/30/2026

💡Managing chronic back pain often starts beyond medication. Learn how exercise, physical therapy, mindfulness and other nonpharmacologic approaches may support improved outcomes for patients.

📚Read expert guidance in Chronic Back Pain: A Healio Guide for Clinicians: https://vist.ly/5kej2

09/29/2026

💡 How does the type and dose of menopausal hormone therapy impact risks for cardiovascular events for women?

Find out in our coverage of this study published in The BMJ 👇

Oral menopausal hormone therapy was linked to elevated risk for venous thromboembolism, and using high-dose oral estradiol may increase risk for ischemic stroke and myocardial infarction, researchers reported in The BMJ. As Healio previously reported, the FDA approved changes to the black box warnin...

09/29/2026

🏃 Before running a marathon, adults with type 1 diabetes should make sure to

📌 have a plan for managing glucose
📌 practice their insulin and carbohydrate strategy during training
📌 use both a CGM and glucometer

Adults with type 1 diabetes can safely complete marathons, according to data presented at the European Association for the Study of Diabetes annual meeting. In a small study assessing runners who competed in the 2025 Pozna Marathon in Poland, researchers found that all 10 runners with type 1 diabete...

09/29/2026

♀️ Many clinicians fail to account for menopause as a cause for a woman’s symptoms, and greater training for healthcare professionals could greatly benefit women’s health.

Learn more about Dr. Jila Senemar’s talk at the Women in Medicine Summit 2026 ⬇️

Many healthcare professionals do not attribute symptoms such as fatigue, mood changes or sleep disruptions to menopause, leading to a missed opportunity for proper treatment in midlife women, according to a speaker. Jila Senemar, MD, FACOG, founder and chief medical officer of JilaMD, said healthcar...

09/29/2026

🤔Tell us YOUR starter word progression~ 👇 Which one was your first? Which one is your current?

🎮Mine is Heart ➡️ Adieu ➡️ Audio ➡️ Brain. Share yours!

09/28/2026

🗣️ Dr. Tessa L. Crume discusses the trajectory of type 1 and type 2 diabetes incidence in Colorado.

Read more about Dr. Crume’s EASD 2026 presentation ⬇️

Incidence of both type 1 and type 2 diabetes increased among children and adolescents from 2002 to 2023, with type 2 diabetes rates rising at a more rapid pace, according to data from the Colorado Diabetes Registry.In findings that will be presented at the European Association for the Study of Diabe...

09/28/2026

💡 Runners with type 1 diabetes can safely complete a marathon, but preparation and the use of both CGM and a glucometer are necessities.

Learn more about this EASD 2026 research ⬇️

https://vist.ly/5k5uh

Adults with type 1 diabetes can safely complete marathons, according to data presented at the European Association for the Study of Diabetes annual meeting. In a small study assessing runners who competed in the 2025 Pozna Marathon in Poland, researchers found that all 10 runners with type 1 diabete...